Share this article
Us Capitol Building Nj

Autoimmune Association Ramps Up Efforts to Eliminate Unwarranted Step Therapy & Other Restrictions

Autoimmune Association has long understood that too many routine insurance plan and PBM practices prevent people with autoimmune diseases and other chronic conditions from getting the medicines they need.

Autoimmune Association is actively promoting passage of the Safe Step Act, bipartisan federal legislation to reform insurance-mandated step therapy practices. This legislation, HR 2279 and S. 2546 in the House and Senate, respectively, would require timely and medically-appropriate appeals processes and other reforms needed to assure that patients get the treatment that is best for them.

As a member of the Safe Step Coalition, Autoimmune Association joined other organizations early in the year in writing to Members of Congress to urge their support for passage of this critical legislation. Similarly, at the state level, Autoimmune Association is collaborating with other advocates to advance of reforms addressing step therapy, utilization management, non-medical switching, and other restrictions on access the medicines patients and their physicians know are best for them.

In March, as part of Autoimmune Diseases Awareness Month (ADAM), Autoimmune Association mobilized patient advocates nationwide in contacting Congress in support of the Safe Step Act. Clearly this legislation is a priority for patients. In the first 24 hours of outreach, hundreds of advocates communicated with legislators, including 50 early-responders who described their frustrations and the harmful consequences of step therapy in their messages.

In April, Autoimmune Association joined the movement to suspend prior authorization and step therapy restrictions in Medicare during the pandemic, as so many beneficiaries with underlying conditions – especially in minority communities, are bearing the brunt of contagion, serious illness, and worse. Through social media, signing-on to an Aimed Alliance Coalition letter to Congress, and our own website advocacy.

The cornerstone of AARDA’s step therapy reform efforts remains the Let My Doctors Decide (LMDD) National Campaign.

Learn More

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

  • Categories

  • Archives

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

Breaking Barriers: Empowering Women of Color Living with Autoimmune Disease Through a Pilot Support Group

The journey to diagnosis for autoimmune disease is challenging, with an average of 4 to 4.5 years overall. In seeking a medical diagnosis...
Autoimmune Association Image Do Not Touch

Lee Thomas Will Deliver Keynote at the Autoimmune Community Summit

Lee Thomas, news anchor and reporter at Fox 2 Detroit TV and national vitiligo advocate, will deliver the keynote address at the third...
Autoimmune Association Image Do Not Touch

Inflation Reduction Act (IRA) Medicare Drug Price Negotiation List Announced

Today, the Centers for Medicare & Medicaid Services (CMS) released the list of medicines it will start directly negotiating within Medicare Part D....
Autoimmune Association Image Do Not Touch

Raising Hope: Sarah Bowlby

Welcome to our inspiring blog series, Raising Hope, where we feature stories of individuals who are making a difference for the autoimmune community...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.